Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD

NCT01376245

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Nanning, Guangxi, China
  • GSK Investigational Site Changsha, Hunan, China
View all 34 locations
View Trial Details
Completed

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD

NCT01636713

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Gaungzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Zhanjiang, Guangdong, China
  • GSK Investigational Site Nanning, Guangxi, China
View all 44 locations
View Trial Details
Completed

Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg

NCT01716520

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Haapsalu, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
View all 21 locations
View Trial Details
Completed

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

NCT02085161

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Torrance, California, United States
  • Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • Boehringer Ingelheim Investigational Site Daw Park, South Australia, Australia
View all 34 locations
View Trial Details
Completed

A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00500318

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +16 more
Locations
  • Forest Investigative Site 2088 Jasper, Alabama, United States
  • Forest Investigative Site 0909 Phoenix, Arizona, United States
  • Forest Investigative Site 0957 Long Beach, California, United States
  • Forest Investigative Site 0973 Los Angeles, California, United States
View all 52 locations
View Trial Details

Related conditions